For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...

The recent decision to merge Genentech’s two cancer departments was made for “scientific reasons,” executives explained to ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

The US Food and Drug Administration (FDA) has approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), the first and ...

It’s unclear if the layoffs are connected to Genentech’s closure of its cancer immunology research department, which Fierce Biotech reported earlier this month would include some layoffs.

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

Genentech has long been known for innovation, but that reputation has been questioned in the wake of multiple rounds of layoffs and the company’s closure of its cancer immunology group.

Biotechnology is at the forefront of innovation, transforming healthcare and pushing the boundaries of what’s possible. As groundbreaking discoveries unfold daily—from cutting-edge therapies to ...

Dr. Beck’s extensive experience in CMC and product development will be instrumental as Abata enters clinical development this ...